Lodestar Investment Counsel Cut Its Metropolitan Life (MET) Holding; Valener (TSE:VNR) Had 0 Analysts Last Week

Among 5 analysts covering Valener Inc (TSE:VNR), 0 have Buy rating, 0 Sell and 5 Hold. Therefore 0 are positive. Valener Inc has $24 highest and $18 lowest target. $22.50’s average target is 2.97% above currents $21.85 stock price. Valener Inc had 14 analyst reports since October 23, 2015 according to SRatingsIntel. Desjardins Securities maintained Valener Inc (TSE:VNR) rating on Monday, August 15. Desjardins Securities has “Hold” rating and $22.50 target. RBC Capital Markets upgraded Valener Inc (TSE:VNR) on Monday, November 30 to “Sector Perform” rating. The firm has “Hold” rating by TD Securities given on Wednesday, March 8. The stock of Valener Inc (TSE:VNR) has “Market Perform” rating given on Friday, October 23 by BMO Capital Markets. The firm has “Sector Perform” rating by RBC Capital Markets given on Friday, November 25. The rating was maintained by TD Securities on Friday, February 10 with “Hold”. See Valener Inc (TSE:VNR) latest ratings:

Lodestar Investment Counsel Llc decreased Metropolitan Life (MET) stake by 2.02% reported in 2017Q3 SEC filing. Lodestar Investment Counsel Llc sold 7,475 shares as Metropolitan Life (MET)’s stock declined 4.70%. The Lodestar Investment Counsel Llc holds 362,550 shares with $18.83M value, down from 370,025 last quarter. Metropolitan Life now has $50.05B valuation. The stock decreased 0.90% or $0.43 during the last trading session, reaching $47.56. About 9.58 million shares traded or 69.97% up from the average. MetLife, Inc. (NYSE:MET) has risen 13.92% since February 4, 2017 and is uptrending. It has underperformed by 2.78% the S&P500.

The stock decreased 1.27% or $0.28 during the last trading session, reaching $21.85. About 61,228 shares traded or 63.86% up from the average. Valener Inc (TSE:VNR) has 0.00% since February 4, 2017 and is . It has underperformed by 16.70% the S&P500.

Valener Inc., through its subsidiaries, distributes natural gas in Canada and the United States. The company has market cap of $850.98 million. The firm operates through Energy Distribution; Natural Gas Transportation; Energy Production; and Energy Services, Storage and Other divisions. It has a 15.97 P/E ratio. It owns and operates a natural gas transportation and distribution system of approximately 1,300 km serving residential and commercial clients in Vermont.

Investors sentiment decreased to 0.89 in 2017 Q3. Its down 0.05, from 0.94 in 2017Q2. It fall, as 61 investors sold MET shares while 336 reduced holdings. 65 funds opened positions while 289 raised stakes. 784.85 million shares or 1.65% more from 772.09 million shares in 2017Q2 were reported. New Mexico Educational Retirement Board, a New Mexico-based fund reported 98,887 shares. Fukoku Mutual Life Ins stated it has 2.28% of its portfolio in MetLife, Inc. (NYSE:MET). Td Asset Mgmt holds 0.49% or 6.27M shares. Moreover, Md Sass Serv has 2.35% invested in MetLife, Inc. (NYSE:MET) for 540,061 shares. Spc Fincl Inc holds 0.06% or 5,017 shares in its portfolio. Chemung Canal Tru Com reported 0.05% of its portfolio in MetLife, Inc. (NYSE:MET). Windward Cap Management Ca stated it has 0.95% of its portfolio in MetLife, Inc. (NYSE:MET). State Of Wisconsin Board owns 1.35M shares for 0.21% of their portfolio. The North Carolina-based Boys Arnold And has invested 0.16% in MetLife, Inc. (NYSE:MET). Rodgers Brothers owns 35,175 shares for 0.64% of their portfolio. American Century stated it has 0.32% of its portfolio in MetLife, Inc. (NYSE:MET). Balasa Dinverno & Foltz Llc invested in 0.04% or 4,709 shares. 301,398 were reported by Boston Advisors Ltd Com. Oppenheimer And Incorporated owns 286,957 shares for 0.4% of their portfolio. Panagora Asset Mgmt stated it has 0.01% in MetLife, Inc. (NYSE:MET).

Lodestar Investment Counsel Llc increased Alphabet Inc Cl C stake by 519 shares to 19,370 valued at $18.58 million in 2017Q3. It also upped Cisco Systems (NASDAQ:CSCO) stake by 9,100 shares and now owns 179,653 shares. Omega Healthcare Investors In (NYSE:OHI) was raised too.

Analysts await MetLife, Inc. (NYSE:MET) to report earnings on February, 7. They expect $1.11 EPS, down 17.78% or $0.24 from last year’s $1.35 per share. MET’s profit will be $1.17 billion for 10.71 P/E if the $1.11 EPS becomes a reality. After $1.09 actual EPS reported by MetLife, Inc. for the previous quarter, Wall Street now forecasts 1.83% EPS growth.

Among 16 analysts covering MetLife (NYSE:MET), 9 have Buy rating, 1 Sell and 6 Hold. Therefore 56% are positive. MetLife has $7800 highest and $46 lowest target. $58.75’s average target is 23.53% above currents $47.56 stock price. MetLife had 47 analyst reports since July 31, 2015 according to SRatingsIntel. The rating was maintained by Keefe Bruyette & Woods on Thursday, December 21 with “Buy”. The rating was reinitiated by Wells Fargo with “Outperform” on Friday, September 23. As per Tuesday, October 3, the company rating was maintained by Wells Fargo. The firm earned “Buy” rating on Wednesday, August 9 by Argus Research. The firm earned “Equal-Weight” rating on Monday, November 13 by Morgan Stanley. As per Thursday, May 25, the company rating was upgraded by FBR Capital. J.P. Morgan initiated the shares of MET in report on Monday, July 24 with “Hold” rating. The firm earned “Buy” rating on Monday, June 27 by Sandler O’Neill. The company was maintained on Tuesday, January 30 by Wells Fargo. RBC Capital Markets maintained the shares of MET in report on Friday, August 4 with “Buy” rating.